Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

EXACT Sciences Corporation (EXAS)

NASDAQ
Currency in USD
Disclaimer
69.06
+2.18(+3.26%)
Closed
After Hours
69.84+0.78(+1.13%)

EXAS Comments

wow
120 go now
For everyone that decided to hold EXAS over night look at the after hours price.
The future is now
Its about the future of medicine
shiotcoin
Congratulations on a good pick ;)
they took approval from FDA ?
Ohio
Lesson 1: don't follow worthless "guru" recommendations! Otherwise you lost your money.
Bottom! on it's way up...
I think we hit the bottom yesterday.  This looks like a repeat of last year.  The CEO sells stock before the end of the year and the price plummets with the bears and short sellers getting their way.  I suspect we will begin a rebound today or within the week.  Look out for a great short term opportunity between now and 2/20 when the annual and quarterly report come out.  here is usually a run up in the price before the report as they usually beat their estimates.  Price targets are averaging around 58.
$40 again! Back to 2018.
excellent product, will not be affected by China trades.
What's happening?
Right?! Haha
Liquid biopsy news.Over bought. Will gap back down tomorrow. Already dropping from high today.
short at this level, this is not a profitable company.
I expect some profit taking today but the reason the company is not profitable is they bought a building last year and spent a fortune on advertising direct to the customer. A smart move because doctors don't like prescribing an at home test that puts their golfing buddies out of a job. This proved very successful and build a prescriber base from 250 to 40,000 growing to 60,000. Now they have a platform to launch a new test for lung cancer with out all the cost. This stock will be $150 in two years.
I started buying options on this stock at $7 and thought it was done at $22. Then they announce a blood test for lung cancer. I'm back in looking at $35.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.